Ebola Outbreak Spurs Rise In Search For Treatment, Vaccine, Other Tropical Disease R&D
News outlets report on the search for an effective Ebola treatment.
The Economist: Fast-tracking treatments
“…The scale of the present [Ebola] outbreak, together with the fear and suffering it is causing, has resulted in a burst of scientific activity to find new treatments and vaccines. Some of these medicines look promising. But to contain the spread of Ebola, scientists and health officials will have to bypass many of the existing rules that govern the delivery of new drugs, and develop potential remedies with unprecedented speed…” (9/13).
Wall Street Journal: Glaxo’s Ebola Vaccine and the Rise of Tropical Disease R&D
“One surprising feature of the Ebola outbreak is that drug giant GlaxoSmithKline PLC was already developing a vaccine for the disease, which kills fewer than 100 people on average a year. Are drug companies finally becoming more interested in neglected tropical diseases?… [F]inancial arguments may finally be leading Big Pharma to increase its minuscule investment in research and development of new drugs for tropical diseases…” (Plumridge, 9/11).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.